Atlas Trials

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Clinical trial NCT01310855 · TERMINATED

Trial details

NCT number
NCT01310855
Sponsor
University College, London
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2011-05-01
Primary completion
2013-05-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.